Skip to main content
. 2012 Jan 2;46(2):153–159. doi: 10.2478/v10019-012-0002-6

TABLE 1.

Distribution of patients according to the selected regimens

Number %
R-ACVBP 19 6.4
R-CHOP 253 85.8
R-CHOP+MTX 12 4.1
R-CHOP/R-other 11 3.7
Total 295 100.0

R-ACVBP = rituximab, doxorubicin, cyclophosphamide, vincristine, bleomycin, prednisolone; R-CHOP = rituximab, doxorubicin, cyclophosphamide, vincristine, prednisolone; R-CHOP+MTX = rituximab, doxorubicin, cyclophosphamide, vincristine, prednisolone, middle-dose methotrexate; R-CHOP/R-other = R-CHOP with reduced doses of doxorubicin + etoposide